Intervention

Memantine Hydrochloride

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions8

Lead sponsors shown3

Clinical trials

3 shown

Memantine Hydrochloride in Prostate Cancer PatientsNCT07164794 · 2025-11-01

NOT_YET_RECRUITING

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityNCT04804644 · 2021-06-08

ACTIVE_NOT_RECRUITING

Memantine Treatment in Alzheimer's Disease PatientsNCT03168997 · 2017-07-15

Common conditions

Alzheimer Disease1 Metastatic Castration-resistant Prostate Cancer (mCRPC)1 Metastatic Lung Small Cell Carcinoma1 Metastatic Malignant Neoplasm in the Brain1 Neuroendocrine Prostate Cancer (NEPC)1 Prostate Cancer1 Recurrent Lung Small Cell Carcinoma1 Stage IV Lung Cancer AJCC v81

Leading sponsors

Bin Xu1 NRG Oncology1 Wei Cuibai1

Trial status mix

ACTIVE_NOT_RECRUITING1

NOT_YET_RECRUITING1

UNKNOWN1

Phase mix

PHASE21

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.